Switch View
© PR Newswire
12.11.2025
ISIN: US90240B1061
Tyra Biosciences Inc
TYRA
LISTED
NASDAQ
Tyra Biosciences Announces Participation at Upcoming Investor Events
News Preview
CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company manag...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US2854091087
Electromed, Inc.
ELMD
LISTED
XASE
Electromed, Inc. Announces First Quarter Fiscal 2026 Results
News Preview
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 (“Q1 FY 2026”).
Q1 FY 2026 Company Highlights
Net revenues increased 15.1% to $16.9 million in Q1 FY 2026, from $14.7 million in the first quarter of the p...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2025.
“Our recent strategic financings further strengthen our balance sheet, significantly increase our cash runway, and allow us to accelerate our invest...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
12.11.2025
ISIN: US7599101026
KORU Medical Systems Inc
KRMD
LISTED
NASDAQ
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
News Preview
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2025.
Recent High...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
12.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
agilon health to Participate in the 8th Annual Evercore Healthcare Conference
News Preview
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 3:00pm ET.
Interested investors and other parties may listen to a sim...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US22053A1079
Quince Therapeutics Inc
CRTX
LISTED
NASDAQ
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on the company’s development pipeline and reported financial results for the third quarter ended September 30, 2025.
Dirk Thye, M.D., Quince’s Chief...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US88338N2062
TherapeuticsMD Inc
TXMD
LISTED
NASDAQ
TherapeuticsMD Announces Third Quarter 2025 Financial Results
News Preview
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2025.
Third Quarter 2025 Financial Results
Net Income (Loss) from Continuing Operations
Net income from continuing operations was $50 thous...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US3847471014
Grail, Inc.
GRAL
LISTED
NASDAQ
GRAIL Reports Third Quarter 2025 Financial Results
News Preview
Q3 U.S. Galleri Revenue Grew
28%
Year-Over-Year to
$32.6 Million
Q3 Galleri Tests Sold Grew 39% Year-Ove...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat immune-mediated diseases, today reported financial results for the third quarter ended September 30, 2025.
In October, Kezar announced that it has been unable to align with the Food and Drug Administration (FDA) o...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US0373261058
AN2 Therapeutics Inc
ANTX
LISTED
NASDAQ
AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights
News Preview
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the third quarter ended September 30, 2025.
“This quarter, we continued to execute across a diverse pipeline spanning multiple,...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced positive, updated interim clinical data in the pediatric cohort (ages 4-10 cohort) from its ongoing Phase 1/2 trial evaluating NGN-401 gene therapy for the treatme...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
News Preview
Cytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026....
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to present at upcoming investor conferences
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
Stifel 2025 Healthcare Conference on Thursday, November 13, 2025
Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
A live webcast of these presentations can be accessed on...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
News Preview
REYKJAVIK, Iceland, November 12, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary of recent pipeline and corporate highlights. Management...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
News Preview
REYKJAVIK, Iceland, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary of recent pipeline and corporate highli...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: CA72706K1012
Planet 13 Holdings Inc.
PLTH
LISTED
CSE
Planet 13 Announces Q3 2025 Financial Results
News Preview
All figures are reported in United States dollars ($) unless otherwise indicated...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Reports Third Quarter 2025 Financial Results
News Preview
iAnthus Reports Third Quarter 2025 Financial Results...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US29772L1089
Eton Pharmaceuticals Inc
ETON
LISTED
NASDAQ
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
News Preview
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings at the 16th Annual Craig-...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare, Inc. to Present at the 2025 Stephens Annual Investment Conference
News Preview
HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference:
November 20, 2025 at 1:00pm CT at the 2025 Stephens Annual Investment Conference
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Co...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.
“We are confident in our ability to deliver on the targets we outlined today. LivaNova’s talented team is focused on a revitalized innovation strategy and op...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US03589W1027
Annexon Inc
ANNX
LISTED
NASDAQ
Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
News Preview
BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has commenced an underwritten public offering of $75 million of sh...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US39037G1094
Great Elm Group, Inc.
GEG
LISTED
NASDAQ
Great Elm Group Reports Fiscal 2026 First Quarter Financial Results
News Preview
GREAT ELM GROUP REPORTS FISCAL 2026 FIRST QUARTER FINANCIAL RESULTS...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Announces Planned CFO Transition in 2026
News Preview
Company initiates search for successor Company initiates search for successor...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
News Preview
ROCKVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced its third quarter ended September 30, 2025 financial results and rei...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US5019761049
Kyverna Therapeutics, Inc.
KYTX
LISTED
NASDAQ
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous guidance of first half 2026; BLA submission anticipated in 1H 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
News Preview
- Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP -...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology to Participate in Upcoming Investor Conference
News Preview
SAN DIEGO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the following investor conference:...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US26745T1016
Dyadic International Inc
DYAI
LISTED
NASDAQ
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
News Preview
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US7504911022
RadNet Inc
RDNT
LISTED
NASDAQ
GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
News Preview
GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US6876041087
Oruka Therapeutics, Inc.
ORKA
LISTED
NASDAQ
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
ORKA-001 Phase 1 results presented at EADV show potential for once-per-year dosing, higher efficacy and off-treatment remission...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US59064R1095
Mesa Laboratories, Inc
MLAB
LISTED
NASDAQ
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
News Preview
LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences:...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Halper Sadeh LLC Encourages HSII, MRUS, ATXS Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
NEW YORK, Nov. 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for pote...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
News Preview
PHILADELPHIA, Nov. 12, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Therapeutics, Inc. ("Akero" or the "Company") about an investigation into the Company and members of its Board of Directors for potential breaches of fiduciary duties and violations of the federal securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
News Preview
PHILADELPHIA, Nov. 12, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
News Preview
Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood pressure and cholesterol
Results demonstrate the...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Nov. 12, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH)....
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX)....
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Sacramento Youth Gain Mentorship and New Career Pathways through $100,000 Health Net Grant to Sacramento County Office of Education
News Preview
The investment backs a peer-mentorship convening and a new online workforce map to create clear pathways into mental-health jobs for local youth
SACRAMENTO, Calif., Nov. 12, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed c...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR)....
Themefolio
Profiler
Peergroup
© EQS Newswire
12.11.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Montega AG: Medios AG | Rating: Kaufen
News Preview
Original-Research: Medios AG - von Montega AG
12.11.2025 / 17:19 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss......
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025
News Preview
Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 45 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
News Preview
Press release – No. 16 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: DK0060027142
ALK-Abelló A/S
ALK B
LISTED
CPH
Nine-month interim report (Q3) 2025 (unaudited)
News Preview
ALK delivers 18% global organic revenue growth with operating profit up 41% in Q3...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: DK0060027142
ALK-Abelló A/S
ALK B
LISTED
CPH
ALK upgrades its full-year outlook
News Preview
Inside information...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform
News Preview
- The collaboration will leverage General Proximity's OmniTAC™ platform to identify and advance next generation induced proximity agents for high value oncology targets.
- Induced proximity medicines, powered by the OmniTAC™ platform, enable precise modulation o...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
News Preview
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Dave Denton, Chief Financial Officer, Executive Vice President, at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 a.m. GMT.
To view and listen to the webcast, visit our web site at www.pfizer.c...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US64131A1051
Neuronetics Inc
STIM
LISTED
NASDAQ
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
News Preview
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at iRhythm caused the company to mis...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
News Preview
SALT LAKE CITY, Nov. 12, 2025 /PRNewswire/ -- Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a patented platform for developing advanced molecular diagnostic tests, following its recent announcement of the formation of CoM...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
News Preview
Patent Extends Protection for Novel Vaccine Targeting a Cancer Projected to Strike Nearly 300,000 U.S. Women in 2026
SAN JOSE, Calif., Nov. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focuse...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
News Preview
- Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - ...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver joins the board as an independent director and will serve on the board’s Audit Committee and Cybersecurity and Data Oversight Commit...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US4333131039
Hinge Health, Inc.
HNGE
LISTED
NYSE
Hinge Health announces $250 million share repurchase program
News Preview
Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program.
“During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow1, reflecting the strength and scalability of our business model,” said James Budge, CFO,...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Recover Investment Losses: Class Action Initiated Against Avantor, Inc. (AVTR)
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=176931&wire=5&utm_campaign...
Themefolio
Profiler
Peergroup
© Newsfile
12.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) - Contact Levi & Korsinsky Before January 5, 2026
News Preview
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=17...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet’s FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electro...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
